companydata.dkcompanydata.dk

BACH BOLIGCENTER ApS: Financial statements 2019

CVR: 12024584

Source: annual report 2019, Danish Business Authority

01/05/2018 – 30/04/2019

BACH BOLIGCENTER ApS (CVR 12024584) has filed annual accounts for 2019. In 2019, the company reported a gross profit of DKK -16,800 and a net result of DKK 11,774 compared with DKK 8,592 the year before. Equity in the 2019 report amounted to DKK 1,176,177. The solvency ratio was 98.6%. The company had 1 employee in the financial year.

Gross Profit
DKK -16,800
Profit/Loss
DKK 11,774
Equity
DKK 1,176,177
Total Assets
DKK 1,192,582
Employees
1

Development

YearRevenueGross ProfitProfit/LossEquityEmployees
2019--17K12K1.2M1
2018--18K9K1.2M-
2017--13K78K1.3M-
2016--13K-48K1.2M-
2015--14K234K1.8M-

Official annual report

View the official annual report directly on the page with a Pro subscription.

Screen every Danish company

Combine filters on financials, industry, geography, property and risk, and instantly see which companies match.

Try company screening

About BACH BOLIGCENTER ApS

BACH BOLIGCENTER ApS is a Danish company of the type Anpartsselskab based in Hammel, founded in 1988. The company is registered under the industry Anden finansiel formidling i.a.n.. The company was previously named EMBRYODAN ApS. The management consists of Geo Koch. The company is owned by Geo Koch. The company has 1 employee (2023). In 2026, the company reported a gross profit of DKK -12,635 and a net result of DKK 3,958 compared with DKK -35,885 the year before. Equity in the 2026 report amounted to DKK 243,122.

Source: annual report 2026, Danish Business Authority